Astellas temporarily halts S Korean Gaster-D exports after supplier oversight
This article was originally published in Scrip
Executive Summary
Astellas has been ordered to halt exports of the 20mg oral-dissolving tablet formulation of the H2-antagonist Gaster-D (famotidine) to South Korea for three months, because some shipments of the product contained active ingredient made by a manufacturer which had not been approved by the local regulator.